Company patents
Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. demonstrates a strong and growing focus on Medical Diagnostics & Surgery, which constitutes 76.8% of its portfolio and saw a significant 50.0% YoY growth in 2025, with 11 patents so far in 2026 despite a partial year. Surprisingly, while Drug Delivery Devices remains a substantial area (44.6% of portfolio), its growth has plateaued, showing 0.0% YoY change in both 2025 and 2026, indicating a potential shift in R&D priorities towards surgical innovations over pure drug delivery mechanisms.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
56 US filings (since 2023) · 4 categories · 3 themes
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Patents
Showing 1-10 of 34
Catheter-based Intervention Devices